International Development News
Development News Edition
Give Feedback

Health News Roundup: Mental health issues in Hong Kong; Novartis to sell epinephrine shot in U.S. pharmacies

Updated: 10-07-2019 02:39 IST
Health News Roundup: Mental health issues in Hong Kong; Novartis to sell epinephrine shot in U.S. pharmacies

Following is a summary of current health news briefs.

Opting out of procedures during childbirth tied to discrimination

(Reuters Health) - Women who decline certain procedures - such as cesarean delivery or immediate cord clamping - during childbirth are more likely to report being treated poorly during their hospital stay, a U.S. study finds. The new mothers said the discrimination they perceived from staff could have been related to their health insurance status, race and ethnicity, or their difference of opinion with the healthcare provider, the study authors report in the journal Social Science and Medicine.

Trump administration drug officials clash over how to combat fentanyl copycats

Trump administration officials are divided over part of a proposal to crack down on illicit versions of fentanyl, the deadly synthetic painkiller that U.S. President Donald Trump targeted in declaring a national opioid abuse emergency. In an inter-agency dispute that highlights the challenges of curbing opioid abuse, the U.S. Drug Enforcement Administration (DEA) is publicly backing tighter rules for fentanyl analogues, which are slightly altered copycat versions of the powerful drug fueling an explosion in overdoses.

Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage

Novartis AG said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local pharmacies across the United States, as a shortage of Mylan NV's EpiPen emergency allergy treatment drags on due to manufacturing problems. Novartis' Sandoz unit launched the Symjepi epinephrine shots for use in hospitals in January and had said it would make the treatment available in pharmacies in a phased manner.

U.S. judge strikes down Trump administration rule requiring drug prices in TV ads

A federal judge on Monday dealt a blow to the Trump administration by striking down a new rule that would have forced pharmaceutical companies to include the wholesale prices of their drugs in television advertising. U.S. District Judge Amit Mehta in Washington sided with drugmakers Merck & Co Inc , Eli Lilly and Co and Amgen Inc by halting the U.S. Department of Health and Human Services (HHS) rule from taking effect on Tuesday as planned.

Mental health issues in Hong Kong surging amid tumultuous protests, experts say

Stress and trauma over the political turmoil surrounding Hong Kong's extradition bill has created an unprecedented mental health problem that the city is not equipped to deal with, medical professionals say. Discussion of mental health carries a huge stigma in the Chinese-ruled territory, and younger people are particularly vulnerable because of the stresses of everyday life: exorbitant living costs, cramped housing, academic pressure and a gloomy view of the future, medical professionals say.

WHO keeps key lung cancer drugs off its essential medicines list

The world's master list of recommended medicines got an update on Tuesday when the World Health Organization (WHO) published a biennial revision, adding 28 drugs including an abortion pill but leaving out several breakthrough treatments for lung cancer. The WHO's Essential Medicines List, which includes treatments that the WHO regards as global standards that should be available everywhere, aims to help governments make the best choices for their health systems.

Caregiver depression tied to more ER visits for dementia patients

(Reuters Health) - Dementia patients may go to the emergency room more often when their caregivers are depressed, a recent study suggests. Researchers observed 663 dementia patients and their family caregivers - typically spouses, domestic partners or other relatives - for six months. At the start of the study, 84 caregivers, or almost 13%, had depression.

Aggressive breast cancers more likely to hit black and younger women

Black and younger women face elevated risks of developing breast cancers that are not only aggressive but also less responsive to treatment, a new study confirms. Researchers found that non-Hispanic black women were more than twice as likely as white women to be diagnosed with so-called triple-negative breast cancers, while women under 40 were nearly twice as likely to be diagnosed with the aggressive cancer as those aged 50 to 64, according to the study published in Cancer.

France will end healthcare refunds for homeopathic drugs

France will end social security reimbursements for homeopathic drugs and the new policy - which has drawn the fire of alternative medicine advocates - will take full effect in 2021, the healthcare minister said on Tuesday. Earlier this year the French health watchdog recommended the move, citing what it said was the insufficient effectiveness of the drugs after an investigation into how they affected conditions such as anxiety or foot warts.

Appeals court panel grills Democratic defenders on constitutionality of Obamacare

A federal appeals court panel grilled Democratic attorneys general on Tuesday about whether Obamacare violates the U.S. Constitution, as it weighs whether to uphold a Texas judge's ruling striking down the landmark healthcare reform law. The judges focused on whether the 2010 Affordable Care Act lost its justification after Republican President Donald Trump in 2017 signed a law that eliminated a tax penalty used to enforce the ACA's mandate that all Americans buy health insurance.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)